SEC Form 4 · accession 0001209191-15-014665
Auspex Pharmaceuticals, Inc. · ASPX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
Feb 12, 2015
Accepted (ET)
Feb 17, 2015 · 5:40 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001454189
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 12, 2015 | S | 66,138 | $62.9612 | D | 3,018,982 | D | |
| Common Stock | Feb 12, 2015 | S | 12,675 | $64.00 | D | 3,006,307 | D | |
| Common Stock | Feb 13, 2015 | S | 40,786 | $62.983 | D | 2,965,521 | D | |
| Common Stock | Feb 12, 2015 | S | 1,696 | $62.9612 | D | 77,461 | I | By: CMEA Ventures VII (Parallel) LP |
| Common Stock | Feb 12, 2015 | S | 325 | $64.00 | D | 77,136 | I | By: CMEA Ventures VII (Parallel) LP |
| Common Stock | Feb 13, 2015 | S | 1,047 | $62.983 | D | 76,089 | I | By: CMEA Ventures VII (Parallel) LP |
Table II — derivative securities
No Table II lines on this filing.